Houlihan Lokey (HLI) Q4 2026 Earnings Transcript

Houlihan Lokey reported record fiscal 2026 revenue of $2.6 billion, up 10%, with adjusted EPS rising 20% to $7.56; Q4 revenue was $636 million and adjusted EPS was $1.63. Management signaled continued strength in backlog and pipeline, higher restructuring activity, and raised the quarterly dividend 17% to $0.70, while warning that Middle East geopolitical uncertainty and software-sector volatility could pressure near-term Corporate Finance growth. The company also highlighted record M&A opportunities, ongoing share repurchases, and continued investment in AI and technology.

Analysis

The key read-through is that HLI’s earnings power is being driven less by a benign macro and more by cyclical volatility turning into monetizable complexity. That matters because the firm is effectively short certainty: when deal timelines widen, fee recognition slips, but the same uncertainty ultimately creates more restructuring, valuation, and capital solutions work. The market may underappreciate that these offsets are not symmetric in time — M&A softness can hit near-term revenue, while restructuring and portfolio valuation tend to re-rate over subsequent quarters as credit spreads, private credit scrutiny, and sponsor pressure work through the system.

The most important second-order effect is that HLI’s product mix is quietly shifting toward businesses with stronger recurring or quasi-recurring demand and higher structural barriers to entry. Capital Solutions already contributes a meaningful share of Corporate Finance, and the company’s technology/AI spend is really a scale weapon: it should widen the gap versus boutiques that cannot fund model/data infrastructure at the same pace. That creates an industry-consolidation dynamic where HLI can both take share and use acquisitions to fill product/geography gaps, but it also raises the probability that incremental margin expansion is capped if they keep investing ahead of revenue.

Contrarian view: consensus may be too focused on near-term M&A timing noise and not enough on the multi-quarter backlog conversion potential if geopolitical pressure eases. The bigger risk is not demand collapse; it’s prolonged uncertainty keeping revenue recognition choppy while expenses keep compounding, which can flatten EPS upgrades even if the top-line story remains intact. If software dislocation deepens and private equity exits reopen, HLI could see a sharper-than-expected mix improvement in both Corporate Finance and Restructuring, making current expectations look conservative rather than stretched.

Key Decisions for Investors

• Long HLI vs short a basket of lower-quality advisory boutiques for 3-6 months: HLI should capture share from firms that lack scale in AI, data, and cross-border coverage while maintaining a better backlog conversion profile.
• Buy HLI on any 5-8% post-earnings dip over the next 2-4 weeks; use the selloff to add because the first quarter risk is timing-related, while the second-half setup is supported by restructuring and sponsor monetization tailwinds.
• Pair trade: long HLI / short a regional investment bank or advisory-heavy financials ETF for 2 quarters, betting that diversified fee mix and capital-solutions exposure outperform pure M&A beta if volatility persists.
• If you want defined risk, buy HLI call spreads 4-6 months out; the thesis is multiple expansion on sustained backlog conversion, but upside is capped if expense growth keeps pace with revenue.
• Trim or avoid short exposure until the market sees one more quarter of fee slippage; the near-term catalyst for reversal is any evidence that deal timelines are normalizing and restructuring wins are closing faster than expected.